KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)

Ginkgo Bioworks Holdings' Interest Expenses history spans 4 years, with the latest figure at $31.4 million for Q4 2024.

  • For Q4 2024, Interest Expenses fell 28.72% year-over-year to $31.4 million; the TTM value through Sep 2025 reached $31.4 million, up 28.34%, while the annual FY2024 figure was $94000.0, 1.08% up from the prior year.
  • Interest Expenses reached $31.4 million in Q4 2024 per DNA's latest filing, up from -$9.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $44.0 million in Q4 2023 to a low of -$15.0 million in Q3 2023.
  • Average Interest Expenses over 4 years is $2.9 million, with a median of $570500.0 recorded in 2020.
  • The largest YoY upside for Interest Expenses was 38.41% in 2024 against a maximum downside of 28.72% in 2024.
  • A 4-year view of Interest Expenses shows it stood at $590000.0 in 2020, then dropped by 6.61% to $551000.0 in 2021, then skyrocketed by 7886.75% to $44.0 million in 2023, then dropped by 28.72% to $31.4 million in 2024.
  • Per Business Quant, the three most recent readings for DNA's Interest Expenses are $31.4 million (Q4 2024), -$9.3 million (Q3 2024), and -$10.3 million (Q2 2024).